<DOC>
	<DOCNO>NCT02129400</DOCNO>
	<brief_summary>The purpose study analyze effect xenon-inhalation erythropoetin-level blood healthy volunteer determine efficient time inhalation . Hypothesis : Xenon-inhalation enhances erythropoetin-levels blood</brief_summary>
	<brief_title>Influence Erythropoetin-level Xenon</brief_title>
	<detailed_description>Xenon-gas approve anesthetic EMEA use balance anesthesia combination opioids adult american society anesthesiology classification ASA ≤ III . Several clinical pre-clinical study show positive effect xenon several organ function brain , kidneys heart . In two study , enhance expression hypoxia inducible factor-1α ( HIF-1α ) could show animal kidney kidney cell . Interestingly , HIF-1α lead enhance formation erythropoetin ( EPO ) . This might result enhanced oxygen transport capacity enhance oxygen-level xenon-treatment . Aim project analyze effect xenon-inhalation circulate erythropoetin-level blood healthy volunteer randomize control pilot study . Besides , positive stimulating factor erythropoiesis ( HIFa stabilize factor ) growth factor ( fibroblast growth factor ( FGFs ) , hepatocyte growth factor ( HGF ) , mechano growth factor ( MGFs ) , platelet-derived growth factor ( PDGFs ) , vascular endothelial growth factor ( VEGFs ) ) shall analyze .</detailed_description>
	<mesh_term>Xenon</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Male subject Age : &gt; 18 year legally competent sign without know medical condition medication prescribe University Hospital RWTH Aachen , Germany Persons able willing understand follow instruction study personnel Signed informed consent Smoker , alcoholic person regularly consume drug medication Persons medical condition contraindicate planned treatment Known hypersensitivity xenon Persons legally competent sign Simultaneous participation trial Bloodloss due trauma period study 2 month previous Blood donation period study 2 month previous</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Xenon-inhalation</keyword>
	<keyword>Erythropoetin</keyword>
	<keyword>Pharmakokinetic</keyword>
	<keyword>Pharmacodynamic</keyword>
	<keyword>Hemodynamic parameter</keyword>
	<keyword>Inflammatory parameter</keyword>
	<keyword>Growth factor</keyword>
	<keyword>Oxidative stress parameter</keyword>
</DOC>